GNNSF (Genscript Biotech) Inventory Turnover: 5.31 (As of Dec. 2025)

What is Genscript Biotech Inventory Turnover?

Genscript Biotech GNNSF 68 Inventory Turnover is 5.31 as of Dec. 2025. GuruFocus rates GNNSF with a GF Score™ of 68/100 and a GF Value™ of $2.81 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Genscript Biotech's Cost of Goods Sold for the six months ended in Dec. 2025 was $208.2 Mil. Genscript Biotech's Average Total Inventories for the quarter that ended in Dec. 2025 was $39.2 Mil. Genscript Biotech's Inventory Turnover for the quarter that ended in Dec. 2025 was 5.31.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Genscript Biotech's Days Inventory for the six months ended in Dec. 2025 was 34.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Genscript Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.09.

Genscript Biotech (OTCPK:GNNSF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Genscript Biotech's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	39.198	/	208.18	*	365 / 2
	=	34.36

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Genscript Biotech's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	39.198	/	440.753
	=	0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Genscript Biotech Inventory Turnover Related Terms

Genscript Biotech Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Genscript Biotech's Inventory Turnover can be seen below:

Genscript Biotech Inventory Turnover Chart

Genscript Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

5.46

6.17

5.12

7.63

11.50

Genscript Biotech Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial															1.40	2.91	4.17	5.67	5.31

68GF Score

Genscript Biotech Corp GNNSF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Genscript Biotech Inventory Turnover Calculation

Genscript Biotech's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	406.322	/ (	(31.097	+	39.594)	/	2 )
=	406.322	/	35.3455
=	11.50

Genscript Biotech's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	208.18	/ (	(38.802	+	39.594)	/	2 )
=	208.18	/	39.198
=	5.31

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 5.31 mean?

Genscript Biotech (GNNSF) has a Inventory Turnover of 5.31 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Genscript Biotech and its competitors.

Is Genscript Biotech's Inventory Turnover too high?

Genscript Biotech's current Inventory Turnover is 5.31. Overall, Genscript Biotech has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Genscript Biotech's Inventory Turnover compare to VRTX and REGN?

Genscript Biotech's Inventory Turnover of 5.31 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Genscript Biotech and its competitors. Genscript Biotech's current Inventory Turnover is 5.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Genscript Biotech stock overvalued right now?

Based on GuruFocus' analysis, Genscript Biotech (GNNSF) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.81, compared to a current price of $1.50 — trading 46.6% below its estimated fair value. The current Inventory Turnover is 5.31. Genscript Biotech's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Genscript Biotech (GNNSF), the current Inventory Turnover is 5.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genscript Biotech (GNNSF) Overvalued in 2026?

Based on GuruFocus' analysis, Genscript Biotech stock appears to be undervalued. The current stock price of $1.50 is trading 46.6% below its estimated GF Value™ of $2.81. GuruFocus considers Genscript Biotech to be Significantly Undervalued.

Key valuation signals for GNNSF:

Inventory Turnover: 5.31
GF Value™: $2.81 vs. price of $1.50 (46.6% below fair value)
GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the GNNSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genscript Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies HKSE:09969 HKSE:02162 HKSE:01877 HKSE:02696 HKSE:09606 HKSE:07666 HKSE:06872 HKSE:06855 HKSE:02335 HKSE:01779 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 01548:Hong Kong G51:Germany

Address 860 Centennial Avenue, Piscataway, NJ, USA, 08854

Website https://www.genscript.com

GenScript Biotech Corp is an investment holding company engaged in the manufacture and sale of life science research products and services, including life science services and products, biologics development services, and industrial synthetic biology products. Its segments include life science services and products, which generate maximum revenue and provide research services and products; biologics development services, which support the development of therapeutic antibodies and CGT products; industrial synthetic biology, which provides enzyme development and production using engineered microbial strains; and the operation unit, which provides shared services. It operates in Mainland China, which generates maximum revenue, U.S., Europe, and the Asia Pacific excluding Mainland China.

68GF Score

Get the complete analysis for GNNSF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.50

Price

$2.81

GF Value

View GNNSF Analysis

See Inventory Turnover data for all stocks →